Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

NCT03497806 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile Infection
Recurrent Clostridium Difficile Infection
C. Diff
CDI
Recurrent C. Diff
rCDI
C. Difficile
Recurrent CDI
FMT
Fecal Microbiota
Fecal Transplant

Interventions

BIOLOGICAL: CP101

Sponsor

Finch Research and Development LLC.

Collaborators

[object Object]